NASDAQ:CASI

CASI Pharmaceuticals SEC Filings & 10K Form

$1.64
-0.07 (-3.80 %)
(As of 06/15/2021 02:26 PM ET)
Add
Compare
Today's Range
$1.64
$1.71
50-Day Range
$1.42
$2.15
52-Week Range
$1.32
$3.90
Volume6,738 shs
Average Volume818,044 shs
Market Capitalization$229.97 million
P/E RatioN/A
Dividend YieldN/A
Beta0.15

CASI Pharmaceuticals (NASDAQ:CASI) SEC Filings

DateFilerForm TypeView
06/07/2021
4:30 PM
CASI Pharmaceuticals (Filer)
Form DEFA14A
05/13/2021
8:45 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2021
10:33 AM
CASI Pharmaceuticals (Filer)
Form DEF 14A
03/30/2021
3:52 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
3:50 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2021
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2021
4:18 PM
CASI Pharmaceuticals (Filer)
Form 424B5
03/12/2021
8:20 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2021
2:09 PM
CASI Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G
02/16/2021
1:20 PM
CASI Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
Form SC 13G
02/12/2021
2:01 PM
CASI Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G
02/10/2021
4:29 PM
CASI Pharmaceuticals (Filer)
Form 10-Q/A
02/10/2021
4:04 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2021
3:02 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2020
3:02 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
3:05 PM
CASI Pharmaceuticals (Issuer)
Xu Weihao (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:05 PM
CASI Pharmaceuticals (Issuer)
Xu Weihao (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2020
3:43 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2020
11:15 PM
CASI Pharmaceuticals (Filer)
Form EFFECT
11/24/2020
4:39 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2020
3:06 PM
CASI Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/09/2020
3:30 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
1:39 PM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2020
3:26 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/02/2020
3:02 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2020
3:02 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
3:04 PM
CASI Pharmaceuticals (Subject)
SPECTRUM PHARMACEUTICALS INC (Filed by)
Form SC 13D/A
08/10/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
11:51 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2020
4:16 PM
CASI Pharmaceuticals (Subject)
He Wei-Wu (Filed by)
Form SC 13D/A
07/24/2020
3:05 PM
CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2020
3:05 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2020
3:18 PM
CASI Pharmaceuticals (Filer)
Form 424B5
07/21/2020
3:13 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2020
3:13 PM
CASI Pharmaceuticals (Filer)
Form 424B5
06/18/2020
5:07 AM
CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:05 AM
CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:04 AM
CASI Pharmaceuticals (Issuer)
Wu Yue Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:03 AM
CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
5:02 AM
CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:14 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2020
4:55 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
2:31 PM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2020
8:45 AM
CASI Pharmaceuticals (Filer)
Form DEF 14A
03/19/2020
4:39 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/16/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2020
2:01 PM
CASI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2020
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
10:01 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2019
9:01 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
3:51 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
3:02 PM
CASI Pharmaceuticals (Filer)
Form 8-K/A
09/24/2019
3:04 PM
CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2019
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
4:25 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2019
3:30 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
10:03 AM
CASI Pharmaceuticals (Filer)
Form CT ORDER
08/15/2019
3:51 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
3:31 PM
CASI Pharmaceuticals (Filer)
Form 424B5
08/09/2019
9:01 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
8:00 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
4:01 PM
CASI Pharmaceuticals (Filer)
Form 424B5
07/19/2019
4:00 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Wu Yue Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
4:01 PM
CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:01 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
12:35 PM
CASI Pharmaceuticals (Filer)
Form CT ORDER
05/15/2019
9:03 AM
CASI Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2019
8:00 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
3:50 PM
CASI Pharmaceuticals (Filer)
Form DEF 14A
04/17/2019
3:03 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2019
3:01 PM
CASI Pharmaceuticals (Subject)
SPECTRUM PHARMACEUTICALS INC (Filed by)
Form SC 13D/A
04/05/2019
3:31 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
3:02 PM
CASI Pharmaceuticals (Filer)
Form PRE 14A
04/04/2019
6:30 PM
CASI Pharmaceuticals (Issuer)
Spectrum Pharmaceuticals Cayman, L.P. (Reporting)
SPECTRUM PHARMACEUTICALS INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
9:22 AM
CASI Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/29/2019
8:00 AM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
4:02 PM
CASI Pharmaceuticals (Filer)
Form NT 10-K
03/13/2019
4:18 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
4:23 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2019
3:07 PM
CASI Pharmaceuticals (Subject)
Zhejiang Kanglaite Group Co., LTD (Filed by)
Form SC 13G/A
02/06/2019
3:06 PM
CASI Pharmaceuticals (Subject)
Li Dapeng (Filed by)
Form SC 13G
02/06/2019
3:04 PM
CASI Pharmaceuticals (Issuer)
Li Dapeng (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2019
6:21 PM
CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
6:19 PM
CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2019
3:46 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
3:02 PM
CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
4:00 PM
CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2018
3:31 PM
CASI Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/06/2018
3:30 PM
CASI Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
12:23 PM
CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
11:15 PM
CASI Pharmaceuticals (Filer)
Form EFFECT
This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.